Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
HF Escobar-Morreale - Nature Reviews Endocrinology, 2018 - nature.com
Polycystic ovary syndrome (PCOS) is one of the most common endocrine and metabolic
disorders in premenopausal women. Heterogeneous by nature, PCOS is defined by a …
disorders in premenopausal women. Heterogeneous by nature, PCOS is defined by a …
The prevalence of polycystic ovary syndrome: a brief systematic review
R Deswal, V Narwal, A Dang… - Journal of human …, 2020 - journals.lww.com
Background: Polycystic ovary syndrome (PCOS), the major endocrinopathy among
reproductive-aged women, is not yet perceived as an important health problem in the world …
reproductive-aged women, is not yet perceived as an important health problem in the world …
Polycystic ovary syndrome: mechanism and management—volume II
Y Wang, P Leung, R Li, Y Wu, H Huang - Frontiers in Endocrinology, 2023 - frontiersin.org
Polycystic ovary syndrome (PCOS) is a complex endocrine disorder that affects a significant
number of women of reproductive age worldwide (1, 2). It is characterized by a combination …
number of women of reproductive age worldwide (1, 2). It is characterized by a combination …
[HTML][HTML] A review: Brief insight into Polycystic Ovarian syndrome
Polycystic ovarian syndrome (PCOS) is a heterogeneous endocrine disorder with the
underline indication of ovarian cysts, anovulation, and endocrine variation affecting the …
underline indication of ovarian cysts, anovulation, and endocrine variation affecting the …
Polycystic ovary syndrome
Polycystic ovary syndrome (PCOS) affects 5–20% of women of reproductive age worldwide.
The condition is characterized by hyperandrogenism, ovulatory dysfunction and polycystic …
The condition is characterized by hyperandrogenism, ovulatory dysfunction and polycystic …
An update on Polycystic Ovary Syndrome (PCOS): diagnosis, risks, etiology, and treatment options revisited
H Islam, J Masud, YN Islam - 2021 - dspace.bracu.ac.bd
Polycystic Ovary Syndrome or PCOS is the most common endocrine disorder in women of
reproductive age, which is still incurable. Despite its prevalence, little is known about its …
reproductive age, which is still incurable. Despite its prevalence, little is known about its …
The pathogenesis and treatment of polycystic ovary syndrome: What's new?
S Bednarska, A Siejka - Advances in Clinical and …, 2017 - publicum.umed.lodz.pl
Polycystic ovary syndrome (PCOS) is currently the leading cause of menstrual complications
in women. It is characterized by clinical and/or biochemical hyperandrogenism, ovulation …
in women. It is characterized by clinical and/or biochemical hyperandrogenism, ovulation …
[HTML][HTML] Diagnosis, Management, and Associated Comorbidities of Polycystic Ovary Syndrome: A Narrative Review
R Choudhari, S Tayade, A Tiwari, P Satone - Cureus, 2024 - ncbi.nlm.nih.gov
Polycystic ovary syndrome (PCOS) is the most widespread and diverse endocrine health
issue affecting many adolescent-aged women globally. It is the most frequent illness in …
issue affecting many adolescent-aged women globally. It is the most frequent illness in …
Polycystic ovary syndrome
R Norman, R Wu, M Stankiewicz - 2004 - digital.library.adelaide.edu.au
Polycystic ovary syndrome (PCOS) affects 5-20% of women of reproductive age worldwide.
The condition is characterized by hyperandrogenism, ovulatory dysfunction and polycystic …
The condition is characterized by hyperandrogenism, ovulatory dysfunction and polycystic …
Medical treatment and comorbidity in polycystic ovary syndrome: an updated review
D Glintborg, M Andersen - Current Opinion in Endocrine and Metabolic …, 2020 - Elsevier
Polycystic ovary syndrome (PCOS) is defined by hyperandrogenism, irregular menses, and
polycystic ovaries when other etiologies are excluded. The risk of type 2 diabetes and …
polycystic ovaries when other etiologies are excluded. The risk of type 2 diabetes and …